The Effect of an Additional Bolus Application in Patients With Intrathecal Opiate Administration - a Pilot Study
- Conditions
- Chronic Pain Syndrome
- Interventions
- Drug: opiate with bolus
- Registration Number
- NCT02197741
- Lead Sponsor
- Swiss Paraplegic Research, Nottwil
- Brief Summary
An additional, intermittent bolus application in patients with intrathecal opiate administration for chronic pain syndrome may have a positive effect on the effectiveness of the treatment. Thus, the effect of an additional, intermittent bolus application in patients with intrathecal opiate administration was therefore investigated.
Patients already equipped with an intrathecal opiate pump were enrolled into the study. Each patient was submitted to two treatment periods in randomly chosen order (cross-over design): 1. standard treatment (continuous opiate administration) and 2. continuous opiate administration with intermittent opiate bolus application. Both treatment periods lasted 14 days. Patients were asked to record pain intensity, side effects and satisfaction with the treatment.
The following hypotheses were tested:
* The application of additional opiate boli results in significantly lower pain intensity.
* The application of additional opiate boli does not result in a higher rate of adverse Events.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 10
- chronic pain syndrome
- intrathecal opiate pump
- signed informed consent
- younger than 18 years
- other (than opiate) intrathecal drug administration
- discontent with intrathecal opiate therapy
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description opiate without bolus opiate with bolus continuous opiate administration without bolus application opiate with bolus opiate with bolus continuous opiate administration with additional bolus application
- Primary Outcome Measures
Name Time Method change in pain intensity day 0. day 14, day 28 numeric rating scale from 0 to10
- Secondary Outcome Measures
Name Time Method change in satisfaction with treatment outcome day 0, day 14, day 28 numeric rating scale from 0 to 10
side effects from day 0 to day 28 occurrence rate of side effects